title: Early dietary intervention: long-term effects on blood pressure, brain neuropeptide Y, and adiposity markers.
abstract: Early life nutrition impacts on subsequent risk of obesity and hypertension. Several brain chemicals responsible for both feeding and cardiovascular regulation are altered in obesity. We examined effects of early postnatal overnutrition on blood pressure, brain neuropeptide Y (NPY), and adiposity markers. Rat pup litters were adjusted to either 3 or 12 male animals (overnutrition and control, respectively) on day 1 of life. After weaning, rats were given either a palatable high-fat diet or standard chow. Smaller litter pups were significantly heavier by 17 days of age. By 16 wk, the effect of litter size was masked by that of diet, postweaning. Small and normal litter animals fed a high-fat diet had similar increases in body weight, plasma insulin, leptin, and adiponectin concentrations, leptin mRNA, and fat masses relative to chow-fed animals. An increase in 11beta-hydroxysteroid dehydrogenase-1 mRNA in white adipose tissue, and a decrease in uncoupling protein-1 mRNA in brown adipose tissue in both small litter groups at 16 wk of age, may represent a programming effect of the altered litter size. NPY concentration in the paraventricular nucleus of the hypothalamus was reduced in high fat-fed groups. Blood pressure was significantly elevated at 13 wk in high-fat-fed animals. This study demonstrates that overnourishment during early postnatal development leads to profound changes in body weight at weaning, which tended to abate with maturation. Thus the effects of long-term dietary intervention postweaning can override those of litter size-induced obesity.
authors.affiliation: Dept. of Pharmacology, The Univ. of Melbourne, Victoria 3010, Australia.
authors.forename: Elena
authors.initials: E
authors.lastname: Velkoska
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Cole
authors.forename: Margaret J
authors.initials: MJ
authors.lastname: Morris
mesh_terms: D043205:11-beta-Hydroxysteroid Dehydrogenase Type 1 / Q000096:biosynthesis; D052242:Adiponectin; D002001:Adipose Tissue, Brown / Q000378:metabolism*; D000818:Animals; D000831:Animals, Newborn; D001794:Blood Pressure / Q000502:physiology; D015152:Blotting, Northern; D001835:Body Weight / Q000502:physiology; D001921:Brain / Q000378:metabolism*; D002352:Carrier Proteins / Q000096:biosynthesis; D004041:Dietary Fats / Q000008:administration & dosage*; D005260:Female; D007328:Insulin / Q000097:blood; D036341:Intercellular Signaling Peptides and Proteins / Q000097:blood; D007473:Ion Channels; D020738:Leptin / Q000096:biosynthesis / Q000097:blood / Q000235:genetics; D008297:Male; D008565:Membrane Proteins / Q000096:biosynthesis; D024101:Mitochondrial Proteins; D009478:Neuropeptide Y / Q000378:metabolism*; D009765:Obesity / Q000209:etiology / Q000378:metabolism* / Q000503:physiopathology; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D000071256:Uncoupling Protein 1
chemical_list: D052242:Adiponectin; D002352:Carrier Proteins; D004041:Dietary Fats; D007328:Insulin; D036341:Intercellular Signaling Peptides and Proteins; D007473:Ion Channels; D020738:Leptin; D008565:Membrane Proteins; D024101:Mitochondrial Proteins; D009478:Neuropeptide Y; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha; C000604373:Ucp1 protein, rat; D000071256:Uncoupling Protein 1; D043205:11-beta-Hydroxysteroid Dehydrogenase Type 1